<?xml version="1.0" encoding="UTF-8"?>
<ref id="B92-molecules-26-00431">
 <label>92.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Paiva</surname>
    <given-names>A.M.</given-names>
   </name>
   <name>
    <surname>Pinto</surname>
    <given-names>R.A.</given-names>
   </name>
   <name>
    <surname>Teixeira</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Barbosa</surname>
    <given-names>C.M.</given-names>
   </name>
   <name>
    <surname>Lima</surname>
    <given-names>R.T.</given-names>
   </name>
   <name>
    <surname>Vasconcelos</surname>
    <given-names>M.H.</given-names>
   </name>
   <name>
    <surname>Sousa</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Pinto</surname>
    <given-names>M.</given-names>
   </name>
  </person-group>
  <article-title>Development of noncytotoxic PLGA nanoparticles to improve the effect of a new inhibitor of p53-MDM2 interaction</article-title>
  <source>Int. J. Pharm.</source>
  <year>2013</year>
  <volume>454</volume>
  <fpage>394</fpage>
  <lpage>402</lpage>
  <pub-id pub-id-type="doi">10.1016/j.ijpharm.2013.07.017</pub-id>
  <pub-id pub-id-type="pmid">23856033</pub-id>
 </element-citation>
</ref>
